N E W S
PRESS RELEASE, 19 November 2020
Neuro-Cells® in patient.
PRESS RELEASE, 18 February 2020
Neuroplast raises € 4 million for its stem cell-based technology to treat patients with Spinal Cord Injury.
PRESS RELEASE, 01 May 2019
European Medicines Agency (EMA) has granted Orphan Drug Designation to Neuroplast treatment.